Case Study of the Week

Is the current lung cancer a new primary or a recurrence of a prior epiglottis cancer?
Read More

RedPath in the News

RedPath Integrated Pathology, Inc. Acquired By ExonHit Therapeutics, S.A.
Read

RedPath Integrated Pathology, Inc. Announces Professional Services Agreement with Allegheny General Hospital
Read

More News

Events

More Events

About: News/Events

RedPath Builds on a Convergence of Technology

Laboratory Industry Report
February 2007

Pittsburgh-based RedPath Integrated Pathology is hoping to fill an existing critical need by merging cutting-edge molecular technology tools with standard pathology practice, focusing first on cancer diagnostics.

Download PDF